$112 Million is the total value of Stamos Capital Partners, L.P.'s 42 reported holdings in Q3 2019. The portfolio turnover from Q2 2019 to Q3 2019 was 51.6% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| AAPL | Sell | APPLE INC | $4,300,000 | +6.7% | 19,200 | -4.0% | 3.82% | -5.2% |
| T | Sell | AT&T INC | $4,276,000 | +4.0% | 113,000 | -8.1% | 3.80% | -7.6% |
| TOTL | Sell | SSGA ACTIVE ETF TRspdr tr tactic | $2,966,000 | -19.2% | 59,706 | -20.3% | 2.64% | -28.2% |
| MINT | Sell | PIMCO ETF TRenhan shrt ma ac | $2,950,000 | -19.4% | 28,998 | -19.5% | 2.62% | -28.3% |
| NEAR | Sell | ISHARES US ETF TRsht mat bd etf | $2,950,000 | -19.4% | 58,610 | -19.5% | 2.62% | -28.3% |
| BOND | Sell | PIMCO ETF TR1-3 yr ustreidx | $2,939,000 | -20.1% | 26,984 | -21.2% | 2.61% | -29.0% |
| MSFT | Sell | MICROSOFT CORP | $1,977,000 | -4.9% | 14,220 | -7.2% | 1.76% | -15.5% |
| MA | Sell | MASTERCARD INCcl a | $1,955,000 | -2.3% | 7,200 | -4.0% | 1.74% | -13.2% |
| V | Sell | VISA INC | $1,909,000 | -4.6% | 11,100 | -3.5% | 1.70% | -15.2% |
| CVX | Sell | CHEVRON CORP NEW | $593,000 | -40.6% | 5,000 | -37.5% | 0.53% | -47.2% |
| NFLX | Sell | NETFLIX INC | $320,000 | -67.0% | 1,195 | -53.8% | 0.28% | -70.6% |
| PYPL | Sell | PAYPAL HLDGS INC | $258,000 | -71.3% | 2,487 | -68.1% | 0.23% | -74.5% |
| SQ | Sell | SQUARE INCcl a | $237,000 | -52.4% | 3,832 | -43.6% | 0.21% | -57.6% |
| ILMN | Sell | ILLUMINA INC | $235,000 | -53.6% | 772 | -43.5% | 0.21% | -58.7% |
| IQV | Sell | IQVIA HLDGS INC | $156,000 | -55.9% | 1,044 | -52.5% | 0.14% | -60.7% |
| SYK | Exit | STRYKER CORP | $0 | – | -956 | -100.0% | -0.20% | – |
| BLK | Exit | BLACKROCK INC | $0 | – | -500 | -100.0% | -0.24% | – |
| GSK | Exit | GLAXOSMITHKLINE PLCsponsored adr | $0 | – | -6,000 | -100.0% | -0.24% | – |
| GILD | Exit | GILEAD SCIENCES INC | $0 | – | -3,600 | -100.0% | -0.24% | – |
| CVS | Exit | CVS HEALTH CORP | $0 | – | -4,500 | -100.0% | -0.25% | – |
| HSBC | Exit | HSBC HLDGS PLCspon adr new | $0 | – | -6,000 | -100.0% | -0.25% | – |
| IBB | Exit | ISHARES TRnasdaq biotech | $0 | – | -2,300 | -100.0% | -0.25% | – |
| VZ | Exit | VERIZON COMMUNICATIONS INC | $0 | – | -8,000 | -100.0% | -0.45% | – |
| BTTGY | Exit | BT GROUP PLCadr | $0 | – | -37,000 | -100.0% | -0.47% | – |
| RDSB | Exit | ROYAL DUTCH SHELL PLCspon adr b | $0 | – | -7,500 | -100.0% | -0.49% | – |
| GE | Exit | GENERAL ELECTRIC CO | $0 | – | -70,000 | -100.0% | -0.74% | – |
| MS | Exit | MORGAN STANLEY | $0 | – | -22,800 | -100.0% | -1.00% | – |
| AMLP | Exit | ALPS ETF TRalerian mlp | $0 | – | -102,000 | -100.0% | -1.01% | – |
| XBI | Exit | SPDR SERIES TRUSTs&p biotech | $0 | – | -11,500 | -100.0% | -1.02% | – |
| BX | Exit | BLACKSTONE GROUP L P | $0 | – | -33,111 | -100.0% | -1.54% | – |
| XOP | Exit | SPDR SERIES TRUSTs&p oilgas exp | $0 | – | -75,000 | -100.0% | -2.04% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AT&T INC | 23 | Q2 2024 | 7.1% |
| JPMORGAN CHASE & CO. | 23 | Q2 2024 | 4.8% |
| JOHNSON & JOHNSON | 23 | Q2 2024 | 3.2% |
| MERCK & CO. INC | 23 | Q2 2024 | 3.2% |
| MICROSOFT CORP | 23 | Q2 2024 | 4.2% |
| FORD MTR CO DEL | 23 | Q2 2024 | 3.2% |
| ALPHABET INC | 23 | Q2 2024 | 3.2% |
| CISCO SYS INC | 23 | Q2 2024 | 2.9% |
| APPLE INC | 22 | Q2 2024 | 11.1% |
| BP PLC | 22 | Q2 2024 | 3.9% |
View Stamos Capital Partners, L.P.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| N-PX | 2024-08-29 |
| 13F-HR | 2024-08-13 |
| 13F-HR | 2024-05-14 |
| 13F-HR | 2024-02-13 |
| 13F-HR | 2023-11-13 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-12 |
| 13F-HR | 2023-02-13 |
| SC 13G/A | 2023-01-17 |
| 13F-HR | 2022-11-14 |
View Stamos Capital Partners, L.P.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.